MaxCyte Selling General Administrative vs Non Operating Income Net Other Analysis

MXCT Stock  USD 3.54  0.08  2.21%   
MaxCyte financial indicator trend analysis is infinitely more than just investigating MaxCyte recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MaxCyte is a good investment. Please check the relationship between MaxCyte Selling General Administrative and its Non Operating Income Net Other accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MaxCyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy MaxCyte Stock please use our How to Invest in MaxCyte guide.

Selling General Administrative vs Non Operating Income Net Other

Selling General Administrative vs Non Operating Income Net Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MaxCyte Selling General Administrative account and Non Operating Income Net Other. At this time, the significance of the direction appears to have almost identical trend.
The correlation between MaxCyte's Selling General Administrative and Non Operating Income Net Other is 0.94. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Non Operating Income Net Other in the same time period over historical financial statements of MaxCyte, assuming nothing else is changed. The correlation between historical values of MaxCyte's Selling General Administrative and Non Operating Income Net Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of MaxCyte are associated (or correlated) with its Non Operating Income Net Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Operating Income Net Other has no effect on the direction of Selling General Administrative i.e., MaxCyte's Selling General Administrative and Non Operating Income Net Other go up and down completely randomly.

Correlation Coefficient

0.94
Relationship DirectionPositive 
Relationship StrengthVery Strong

Selling General Administrative

Non Operating Income Net Other

Most indicators from MaxCyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MaxCyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MaxCyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy MaxCyte Stock please use our How to Invest in MaxCyte guide.At this time, MaxCyte's Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.69 in 2025, whereas Enterprise Value Multiple is likely to drop (9.80) in 2025.
 2022 2024 2025 (projected)
Interest Expense126.9K145.9K138.6K
Depreciation And Amortization2.7M4.8M5.0M

MaxCyte fundamental ratios Correlations

0.870.940.951.00.940.83-0.67-0.93-0.450.850.860.480.980.790.880.880.920.960.930.99-0.50.91.00.881.0
0.870.970.920.860.970.67-0.48-0.93-0.420.790.960.320.770.660.780.990.980.890.980.8-0.480.860.910.970.87
0.940.970.980.920.970.77-0.64-0.96-0.430.890.960.380.860.70.840.970.990.90.990.87-0.510.920.960.940.93
0.950.920.980.940.940.84-0.71-0.97-0.390.910.90.370.90.770.870.930.960.910.980.92-0.550.960.970.890.93
1.00.860.920.940.930.83-0.67-0.91-0.460.850.850.50.990.780.880.860.90.950.910.99-0.490.890.990.861.0
0.940.970.970.940.930.72-0.51-0.94-0.530.790.960.470.870.710.850.960.980.940.970.88-0.450.860.960.980.94
0.830.670.770.840.830.72-0.62-0.86-0.260.70.560.250.860.930.890.720.710.840.790.87-0.670.890.80.630.79
-0.67-0.48-0.64-0.71-0.67-0.51-0.620.66-0.04-0.91-0.55-0.14-0.67-0.42-0.59-0.49-0.59-0.47-0.6-0.670.38-0.73-0.66-0.4-0.65
-0.93-0.93-0.96-0.97-0.91-0.94-0.860.660.37-0.86-0.88-0.33-0.87-0.81-0.9-0.94-0.95-0.91-0.97-0.890.54-0.95-0.94-0.88-0.9
-0.45-0.42-0.43-0.39-0.46-0.53-0.26-0.040.37-0.17-0.48-0.87-0.41-0.2-0.46-0.37-0.47-0.44-0.39-0.420.12-0.21-0.48-0.56-0.49
0.850.790.890.910.850.790.7-0.91-0.86-0.170.830.250.80.550.730.790.860.720.860.81-0.450.880.870.720.84
0.860.960.960.90.850.960.56-0.55-0.88-0.480.830.430.750.510.750.930.980.810.930.77-0.340.790.90.950.87
0.480.320.380.370.50.470.25-0.14-0.33-0.870.250.430.480.220.470.270.410.40.320.470.080.220.490.490.53
0.980.770.860.90.990.870.86-0.67-0.87-0.410.80.750.480.820.870.790.830.940.861.0-0.520.870.960.780.97
0.790.660.70.770.780.710.93-0.42-0.81-0.20.550.510.220.820.840.720.660.860.750.83-0.540.840.750.650.73
0.880.780.840.870.880.850.89-0.59-0.9-0.460.730.750.470.870.840.790.830.870.840.88-0.450.830.880.790.87
0.880.990.970.930.860.960.72-0.49-0.94-0.370.790.930.270.790.720.790.970.90.990.81-0.530.890.90.950.86
0.920.980.990.960.90.980.71-0.59-0.95-0.470.860.980.410.830.660.830.970.890.980.85-0.440.890.950.960.91
0.960.890.90.910.950.940.84-0.47-0.91-0.440.720.810.40.940.860.870.90.890.920.95-0.540.860.950.890.94
0.930.980.990.980.910.970.79-0.6-0.97-0.390.860.930.320.860.750.840.990.980.920.87-0.550.940.950.940.91
0.990.80.870.920.990.880.87-0.67-0.89-0.420.810.770.471.00.830.880.810.850.950.87-0.520.880.970.80.98
-0.5-0.48-0.51-0.55-0.49-0.45-0.670.380.540.12-0.45-0.340.08-0.52-0.54-0.45-0.53-0.44-0.54-0.55-0.52-0.6-0.47-0.4-0.46
0.90.860.920.960.890.860.89-0.73-0.95-0.210.880.790.220.870.840.830.890.890.860.940.88-0.60.90.80.86
1.00.910.960.970.990.960.8-0.66-0.94-0.480.870.90.490.960.750.880.90.950.950.950.97-0.470.90.910.99
0.880.970.940.890.860.980.63-0.4-0.88-0.560.720.950.490.780.650.790.950.960.890.940.8-0.40.80.910.88
1.00.870.930.931.00.940.79-0.65-0.9-0.490.840.870.530.970.730.870.860.910.940.910.98-0.460.860.990.88
Click cells to compare fundamentals

MaxCyte Account Relationship Matchups

MaxCyte fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets51.8M284.1M286.7M268.3M308.5M323.9M
Short Long Term Debt Total7.0M5.7M16.1M18.7M21.6M22.6M
Other Current Liab5.2M6.5M8.3M11.3M13.0M13.6M
Total Current Liabilities11.6M15.6M15.4M17.9M20.5M21.6M
Total Stockholder Equity33.2M262.9M254.0M232.2M267.0M280.3M
Property Plant And Equipment Net6.5M13.4M33.6M34.8M40.0M42.0M
Current Deferred Revenue4.8M6.7M6.7M5.1M5.8M3.5M
Net Debt(11.8M)(42.1M)5.0M(27.8M)(25.0M)(23.7M)
Retained Earnings(95.2M)(114.3M)(137.9M)(175.8M)(158.2M)(150.3M)
Accounts Payable890.2K1.8M292K743K668.7K635.3K
Cash18.8M47.8M11.1M46.5M53.5M56.2M
Non Current Assets Total6.5M13.7M34.4M78.1M89.8M94.3M
Non Currrent Assets Other33.9K316.7K809K388K446.2K468.5K
Cash And Short Term Investments34.8M255.0M227.3M168.3M193.5M203.2M
Net Receivables5.2M6.9M11.2M5.8M6.6M4.3M
Common Stock Shares Outstanding69.5M90.6M101.7M103.3M118.8M66.8M
Liabilities And Stockholders Equity51.8M284.1M286.7M268.3M308.5M323.9M
Non Current Liabilities Total6.9M5.6M17.3M18.3M21.0M22.0M
Inventory4.3M5.2M8.6M12.2M14.1M14.8M
Other Current Assets1.0M3.3M6.0M3.9M4.5M4.7M
Total Liab18.6M21.2M32.7M36.1M41.5M43.6M
Total Current Assets45.3M270.4M252.3M190.2M218.7M229.7M
Short Term Debt672.6K527.2K157K774K696.6K794.2K
Common Stock773.8K1.0M1.0M1.0M1.2M1.3M
Other Stockholder Equity127.7M376.2M390.8M406.9M468.0M491.4M
Other Liab338.1K646.6K450.2K1.3M1.5M1.6M
Net Tangible Assets13.6M33.2M262.9M254.0M292.1M306.7M
Common Stock Total Equity574K773.8K1.0M1.0M1.2M807.8K
Capital Lease Obligations2.0M5.7M16.1M18.7M21.6M22.6M
Net Invested Capital38.1M262.9M254.0M232.2M267.0M280.3M
Property Plant And Equipment Gross6.5M7.7M23.7M45.0M51.8M54.4M
Non Current Liabilities Other646.6K450.2K1.3M283K325.5K594.2K
Net Working Capital33.6M254.8M236.8M172.3M198.2M118.2M
Property Plant Equipment5.5M6.5M13.4M23.7M27.3M28.6M
Short Term Investments16.0M207.3M216.3M121.8M140.0M103.8M
Capital Stock773.8K1.0M1.0M1.0M1.2M905.1K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MaxCyte Stock Analysis

When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.